Abstract
We reported the severe adverse event of zoledronate infusion. The point of our case is to emphasize the importance of early recognition of potentially sight-threatening ocular conditions especially the glaucoma or ocular inflammations, as they are readily treatable. Patients also should be informed of these ocular complications, especially at initiation of bisphosphonate therapy and be advised to report any eye symptoms to their physicians. Moreover, doctors should also use bisphosphonates with caution in patients who have a history of glaucoma.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call